Back to search

Article

Allosteric Inhibition of CRISPR-Cas9 by Bacteriophage-derived Peptides

2019-05-20

Abstract excerpt

<h4>Background</h4> CRISPR-Cas9 has been developed as a therapeutic agent for various infectious and genetic diseases. In many clinically relevant applications, constitutively active CRISPR-Cas9 is delivered into human cells without a temporal control system. Excessive and prolonged expression CRISPR-Cas9 can lead to elevated off-target cleavage. The need for modulating CRISPR-Cas9 activity over the dimensions of...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
4bb1d317-7f81-51cc-849e-5fb2ed41c101
DOI
10.1101/642538
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Allosteric Inhibition of CRISPR-Cas9 by Bacteriophage-derived PeptidesDOI 10.1101/642538
Select a neighboring publication to make it the new centre.